<b>BACKGROUND</b>. Artificial intelligence (AI) tools for evaluating low-dose CT (LDCT) lung cancer screening examinations are used predominantly for assisting radiologists' interpretations. Alternate utilization scenarios (e.g., use of AI as a prescreener or backup) warrant consideration. <b>OBJECTIVE</b>. The purpose of this study was to evaluate the impact of different AI utilization scenarios on diagnostic outcomes and interpretation times for LDCT lung cancer screening. <b>METHODS</b>. This retrospective study included 366 individuals (358 men, 8 women; mean age, 64 years) who underwent LDCT from May 2017 to December 2017 as part of an earlier prospective lung cancer screening trial. Examinations were interpreted by one of five readers, who reviewed their assigned cases in two sessions (with and without a commercial AI computer-aided detection tool). These interpretations were used to reconstruct simulated AI utilization scenarios: as an assistant (i.e., radiologists interpret all examinations with AI assistance), as a prescreener (i.e., radiologists only interpret examinations with a positive AI result), or as backup (i.e., radiologists reinterpret examinations when AI suggests a missed finding). A group of thoracic radiologists determined the reference standard. Diagnostic outcomes and mean interpretation times were assessed. Decision-curve analysis was performed. <b>RESULTS</b>. Compared with interpretation without AI (recall rate, 22.1%; per-nodule sensitivity, 64.2%; per-examination specificity, 88.8%; mean interpretation time, 164 seconds), AI as an assistant showed higher recall rate (30.3%; <i>p</i> < .001), lower per-examination specificity (81.1%), and no significant change in per-nodule sensitivity (64.8%; <i>p</i> = .86) or mean interpretation time (161 seconds; <i>p</i> = .48); AI as a prescreener showed lower recall rate (20.8%; <i>p</i> = .02) and mean interpretation time (143 seconds; <i>p</i> = .001), higher per-examination specificity (90.3%; <i>p</i> = .04), and no significant difference in per-nodule sensitivity (62.9%; <i>p</i> = .16); and AI as a backup showed increased recall rate (33.6%; <i>p</i> < .001), per-examination sensitivity (66.4%; <i>p</i> < .001), and mean interpretation time (225 seconds; <i>p</i> = .001), with lower per-examination specificity (79.9%; <i>p</i> < .001). Among scenarios, only AI as a prescreener demonstrated higher net benefit than interpretation without AI; AI as an assistant had the least net benefit. <b>CONCLUSION</b>. Different AI implementation approaches yield varying outcomes. The findings support use of AI as a prescreener as the preferred scenario. <b>CLINICAL IMPACT</b>. An approach whereby radiologists only interpret LDCT examinations with a positive AI result can reduce radiologists' workload while preserving sensitivity.

Medical image segmentation is vital for accurate diagnosis. While U-Net-based models are effective, they struggle to capture long-range dependencies in complex anatomy. We propose GH-UNet, a Group-wise Hybrid Convolution-ViT model within the U-Net framework, to address this limitation. GH-UNet integrates a hybrid convolution-Transformer encoder for both local detail and global context modeling, a Group-wise Dynamic Gating (GDG) module for adaptive feature weighting, and a cascaded decoder for multi-scale integration. Both the encoder and GDG are modular, enabling compatibility with various CNN or ViT backbones. Extensive experiments on five public and one private dataset show GH-UNet consistently achieves superior performance. On ISIC2016, it surpasses H2Former with 1.37% and 1.94% gains in DICE and IOU, respectively, using only 38% of the parameters and 49.61% of the FLOPs. The code is freely accessible via: https://github.com/xiachashuanghua/GH-UNet .

BackgroundHigher-resolution magnetic resonance imaging sequences are needed for the early detection of pancreatic cancer.PurposeTo compare the quality of our novel T2-weighted, high-contrast, thin-slice imaging sequence, with an improved spatial resolution and deep learning-based reconstruction (three-shot turbo spin-echo with deep learning-based reconstruction [3S-TSE-DLR]), for imaging the pancreas with imaging using three conventional sequences (half-Fourier acquisition single-shot turbo spin-echo [HASTE], fat-suppressed 3D T1-weighted [FS-3D-T1W] imaging, and magnetic resonance cholangiopancreatography [MRCP]).Material and MethodsPancreatic images of 50 healthy volunteers acquired with 3S-TSE-DLR, HASTE, FS-3D-T1W imaging, and MRCP were compared by two diagnostic radiologists. A 5-point scale was used for assessing motion artifacts, pancreatic margin sharpness, and the ability to identify the main pancreatic duct (MPD) on 3S-TSE-DLR, HASTE, and FS-3D-T1W imaging, respectively. The ability to identify MPD via MRCP was also evaluated.ResultsArtifact scores (the higher the score, the fewer the artifacts) were significantly higher for 3S-TSE-DLR than for HASTE, and significantly lower for 3S-TSE-DLR than for FS-3D-T1W imaging, for both radiologists. Sharpness scores were significantly higher for 3S-TSE-DLR than for HASTE and FS-3D-T1W imaging, for both radiologists. The rate of identification of MPD was significantly higher for 3S-TSE-DLR than for FS-3D-T1W imaging, for both radiologists, and significantly higher for 3S-TSE-DLR than for HASTE for one radiologist. The rate of identification of MPD was not significantly different between 3S-TSE-DLR and MRCP.Conclusion3S-TSE-DLR provides better image sharpness than conventional sequences, can identify MPD equally as well or better than HASTE, and shows identification performance comparable to that of MRCP.

To investigate the value of multi-model based on preoperative CT scans in predicting EGFR/TP53 co-mutation status. We retrospectively included 2171 patients with non-small cell lung cancer (NSCLC) with pre-treatment computed tomography (CT) scans and predicting epidermal growth factor receptor (EGFR) gene sequencing from West China Hospital between January 2013 and April 2024. The deep-learning model was built for predicting EGFR / tumor protein 53 (TP53) co-occurrence status. The model performance was evaluated by area under the curve (AUC) and Kaplan-Meier analysis. We further compared multi-dimension model with three one-dimension models separately, and we explored the value of combining clinical factors with machine-learning factors. Additionally, we investigated 546 patients with 56-panel next-generation sequencing and low-dose computed tomography (LDCT) to explore the biological mechanisms of radiomics. In our cohort of 2171 patients (1,153 males, 1,018 females; median age 60 years), single-dimensional models were developed using data from 1,055 eligible patients. The multi-dimensional model utilizing a Random Forest classifier achieved superior performance, yielding the highest AUC of 0.843 for predicting EGFR/TP53 co-mutations in the test set. The multi-dimensional model demonstrates promising potential for non-invasive prediction of EGFR and TP53 co-mutations, facilitating early and informed clinical decision-making in NSCLC patients at risk of treatment resistance.

Accurate prediction of pathological complete response (pCR) to neoadjuvant chemotherapy has significant clinical utility in the management of breast cancer treatment. Although multimodal deep learning models have shown promise for predicting pCR from medical imaging and other clinical data, their adoption has been limited due to challenges with interpretability and generalizability across institutions. We developed a multimodal deep learning model combining post contrast-enhanced whole-breast MRI at pre- and post-treatment timepoints with non-imaging clinical features. The model integrates 3D convolutional neural networks and self-attention to capture spatial and cross-modal interactions. We utilized two public multi-institutional datasets to perform internal and external validation of the model. For model training and validation, we used data from the I-SPY 2 trial (N = 660). For external validation, we used the I-SPY 1 dataset (N = 114). Of the 660 patients in I-SPY 2, 217 patients achieved pCR (32.88%). Of the 114 patients in I-SPY 1, 29 achieved pCR (25.44%). The attention-based multimodal model yielded the best predictive performance with an AUC of 0.73 ± 0.04 on the internal data and an AUC of 0.71 ± 0.02 on the external dataset. The MRI-only model (internal AUC = 0.68 ± 0.03, external AUC = 0.70 ± 0.04) and the non-MRI clinical features-only model (internal AUC = 0.66 ± 0.08, external AUC = 0.71 ± 0.03) trailed in performance, indicating the combination of both modalities is most effective. We present a robust and interpretable deep learning framework for pCR prediction in breast cancer patients undergoing NAC. By combining imaging and clinical data with attention-based fusion, the model achieves strong predictive performance and generalizes across institutions.

Non-alcoholic fatty liver disease (NAFLD) is a significant risk factor for liver cancer and cardiovascular diseases, imposing substantial social and economic burdens. Computed tomography (CT) scans are crucial for diagnosing NAFLD and assessing its severity. However, current manual measurement techniques require considerable human effort and resources from radiologists, and there is a lack of standardized methods for classifying the severity of NAFLD in existing research. To address these challenges, we propose a novel method for NAFLD segmentation and automated severity scoring. The method consists of three key modules: (1) The Semi-automatization nnU-Net Module (SNM) constructs a high-quality dataset by combining manual annotations with semi-automated refinement; (2) The Focal Feature Fusion Swin-Unet Module (FSM) enhances liver and spleen segmentation through multi-scale feature fusion and Swin Transformer-based architectures; (3) The Automated Severity Scoring Module (ASSM) integrates segmentation results with radiological features to classify NAFLD severity. These modules are embedded in a Flask-RESTful API-based system, enabling users to upload abdominal CT data for automated preprocessing, segmentation, and scoring. The Focal Feature Fusion Swin-Unet (FF Swin-Unet) method significantly improves segmentation accuracy, achieving a Dice similarity coefficient (DSC) of 95.64% and a 95th percentile Hausdorff distance (HD95) of 15.94. The accuracy of the automated severity scoring is 90%. With model compression and ONNX deployment, the evaluation speed for each case is approximately 5 seconds. Compared to manual diagnosis, the system can process a large volume of data simultaneously, rapidly, and efficiently while maintaining the same level of diagnostic accuracy, significantly reducing the workload of medical professionals. Our research demonstrates that the proposed system has high accuracy in processing large volumes of CT data and providing automated NAFLD severity scores quickly and efficiently. This method has the potential to significantly reduce the workload of medical professionals and holds immense clinical application potential.

Quantifying diagnostic image quality (IQ) is not straightforward but essential for optimizing the balance between IQ and radiation dose, and for ensuring consistent high-quality images in CT imaging. This review provides a comprehensive overview of advanced objective reference-free IQ assessment methods for CT scans, beyond standard approaches. A literature search was performed in PubMed and Web of Science up to June 2024 to identify studies using advanced objective image quality methods on clinical CT scans. Only reference-free methods, which do not require a predefined reference image, were included. Traditional methods relying on the standard deviation of the Hounsfield units, the signal-to-noise ratio or contrast-to-noise ratio, all within a manually selected region-of-interest, were excluded. Eligible results were categorized by IQ metric (i.e., noise, contrast, spatial resolution and other) and assessment method (manual, automated, and artificial intelligence (AI)-based). Thirty-five studies were included that proposed or employed reference-free IQ methods, identifying 12 noise assessment methods, 4 contrast assessment methods, 14 spatial resolution assessment methods and 7 others, based on manual, automated or AI-based approaches. This review emphasizes the transition from manual to fully automated approaches for IQ assessment, including the potential of AI-based methods, and it provides a reference tool for researchers and radiologists who need to make a well-considered choice in how to evaluate IQ in CT imaging. This review examines the challenge of quantifying diagnostic CT image quality, essential for optimization studies and ensuring consistent high-quality images, by providing an overview of objective reference-free diagnostic image quality assessment methods beyond standard methods. Quantifying diagnostic CT image quality remains a key challenge. This review summarizes objective diagnostic image quality assessment techniques beyond standard metrics. A decision tree is provided to help select optimal image quality assessment techniques.

Super-resolution imaging has emerged as a rapidly advancing field in diagnostic ultrasound. Ultrasound Localization Microscopy (ULM) achieves sub-wavelength precision in microvasculature imaging by tracking gas microbubbles (MBs) flowing through blood vessels. However, MB localization faces challenges due to dynamic point spread functions (PSFs) caused by harmonic and sub-harmonic emissions, as well as depth-dependent PSF variations in ultrasound imaging. Additionally, deep learning models often struggle to generalize from simulated to in vivo data due to significant disparities between the two domains. To address these issues, we propose a novel approach using the DEformable DEtection TRansformer (DE-DETR). This object detection network tackles object deformations by utilizing multi-scale feature maps and incorporating a deformable attention module. We further refine the super-resolution map by employing a KDTree algorithm for efficient MB tracking across consecutive frames. We evaluated our method using both simulated and in vivo data, demonstrating improved precision and recall compared to current state-of-the-art methodologies. These results highlight the potential of our approach to enhance ULM performance in clinical applications.

Multiple Sclerosis (MS) is a chronic autoimmune disease that primarily affects the central nervous system and is predominantly diagnosed in adults, making pediatric cases rare and underrepresented in medical research. This paper introduces the first publicly available MRI dataset specifically dedicated to pediatric multiple sclerosis lesion segmentation. The dataset comprises longitudinal MRI scans from 9 pediatric patients, each with between one and six timepoints, with a total of 28 MRI scans. It includes T1-weighted (MPRAGE), T2-weighted, and FLAIR sequences. Additionally, it provides clinical data and initial symptoms for each patient, offering valuable insights into disease progression. Lesion segmentation was performed by senior experts, ensuring high-quality annotations. To demonstrate the dataset's reliability and utility, we evaluated two deep learning models, achieving competitive segmentation performance. This dataset aims to advance research in pediatric MS, improve lesion segmentation models, and contribute to federated learning approaches.

Early prediction of treatment response can facilitate personalized treatment for breast cancer patients. Studies on the I-SPY 2 clinical trial demonstrate that multi-time point dynamic contrast-enhanced magnetic resonance (DCEMR) imaging improves the accuracy of predicting pathological complete response (pCR) to chemotherapy. However, previous image-based prediction models usually rely on mid- or post-treatment images to ensure the accuracy of prediction, which may outweigh the benefit of response-based adaptive treatment strategy. Accurately predicting the pCR at the early time point is desired yet remains challenging. To improve prediction accuracy at the early time point of treatment, we proposed a two-stage dual-task learning strategy to train a deep neural network for early prediction using only early-treatment data. We developed and evaluated our proposed method using the I-SPY 2 dataset, which included DCEMR images acquired at three time points: pretreatment (T0), after 3 weeks (T1) and 12 weeks of treatment (T2). At the first stage, we trained a convolutional long short-term memory (LSTM) model using all the data to predict pCR and extract the latent space image representation at T2. At the second stage, we trained a dual-task model to simultaneously predict pCR and the image representation at T2 using images from T0 and T1. This allowed us to predict pCR earlier without using images from T2. By using the conventional single-stage single-task strategy, the area under the receiver operating characteristic curve (AUROC) was 0.799. By using the proposed two-stage dual-task learning strategy, the AUROC was improved to 0.820. Our proposed two-stage dual-task learning strategy can improve model performance significantly (p=0.0025) for predicting pCR at the early time point (3rd week) of neoadjuvant chemotherapy for high-risk breast cancer patients. The early prediction model can potentially help physicians to intervene early and develop personalized plans at the early stage of chemotherapy.